DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded to “Buy” at StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Several other equities research analysts also recently weighed in on XRAY. Evercore ISI lowered their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Stifel Nicolaus lowered their price target on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Robert W. Baird lowered their price target on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Needham & Company LLC decreased their target price on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a report on Friday, October 25th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $31.88.

DENTSPLY SIRONA Price Performance

Shares of XRAY stock opened at $23.39 on Wednesday. DENTSPLY SIRONA has a 1-year low of $22.84 and a 1-year high of $37.60. The stock’s 50-day moving average is $25.00 and its 200 day moving average is $26.06. The company has a market cap of $4.74 billion, a P/E ratio of -27.20, a PEG ratio of 1.28 and a beta of 1.02. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.33 and a quick ratio of 0.87.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently made changes to their positions in XRAY. Raymond James Trust N.A. boosted its stake in shares of DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock worth $241,000 after acquiring an additional 453 shares during the last quarter. State of Alaska Department of Revenue boosted its stake in shares of DENTSPLY SIRONA by 2.4% in the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares during the last quarter. LRI Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares during the last quarter. Diversified Trust Co boosted its stake in shares of DENTSPLY SIRONA by 3.0% in the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock worth $489,000 after acquiring an additional 566 shares during the last quarter. Finally, Allworth Financial LP boosted its stake in shares of DENTSPLY SIRONA by 40.2% in the third quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 625 shares during the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.